Navigating the Landscape of Review Articles: A Guide for Investigators

Résumé fourni par la source

Review articles are increasingly undertaken by early career investigators and actively published across medical journals, offering a structured entry into scholarship without the logistical demands of interventional trials. However, many early authors struggle to differentiate between the methodologies underpinning various types of reviews. This conceptual ambiguity often leads to inappropriate study design, methodological mislabelling, reviewer criticism and preventable desk rejections; and even when published, such papers may attract post publication correspondence and critical commentary. This expanding trend reflects both opportunity and vulnerability: the volume of reviews is increasing faster than methodological literacy.[1] For example, systematic reviews alone have increased more than 20-fold between 2000 and 2019, with estimates approaching 80 new systematic reviews being published per day by 2019.[2] Growth without proportional rigour has led to inflation of labels – ‘systematic’, ‘scoping’ and ‘meta-analysis’ used aspirationally rather than accurately. This editorial therefore provides a pragmatic orientation to the landscape of review article types, emphasising alignment between research intent, methodological structure, reporting standards and journal expectations, to improve academic credibility, publication success and clinical interpretability. THE CLINICAL IMPERATIVE: WHY REVIEWS MATTER Review articles occupy a central role in modern clinical governance because they convert dispersed primary research into structured, interpretable and clinically actionable knowledge.[3] Individual trials rarely settle questions of safety, superiority or generalisability; it is only through synthesis that evidence acquires decision-making utility. The foundation of evidence-based medicine explicitly positions synthesis, not isolated studies, as the mechanism through which research informs practice.[4] High-quality reviews guard against anecdotal drift and cognitive bias by counterbalancing memorable individual outcomes with the totality of available data, refining indications by clarifying where interventions are effective or ineffective, and delineating genuine equipoise – areas where scientific uncertainty is ethically and intellectually permissible, guiding future trial design.[5,6] In this way, reviews do not merely summarise literature; they mediate between data and care. However, reviews influence practice only when methodological fidelity matches clinical intent. A review strengthens evidence culture when it clarifies rather than collects, interprets rather than recites and critiques rather than compiles. Poorly aligned or superficially executed syntheses risk producing false certainty, particularly when heterogeneous data are pooled for the sake of perceived elevation to ‘meta-analysis’. Ioannidis warns that this phenomenon, an overproduction of poorly conceived evidence syntheses, could distort guideline development and generate research waste rather than prevent it.[6] Thus, the clinical imperative is not fulfilled by format or terminology alone; it is fulfilled when the question, method, eligibility structure, appraisal strategy and interpretive lens are coherent. In this sense, the value of a review is not determined by what it is called, but by what it enables clinicians and researchers to responsibly do. CHOOSING YOUR PATH: WHICH TYPE OF REVIEW? Choosing the type of review is not a matter of preference or prestige; it is a methodological decision anchored to what the researcher is trying to answer. Hence, the question should choose the review, not the author. For example, broad, exploratory questions align with scoping or narrative formats, while focused clinical questions with predefined outcomes require a systematic review. Questions of comparative effectiveness or ranking progress toward meta-analysis or network meta-analysis (NMA) [Table 1]. Misalignment between the intent of the question and the structure of the review is one of the most common reasons manuscripts are rejected.[7] More advanced formats such as umbrella reviews, mixed-methods syntheses, realist reviews or diagnostic accuracy reviews, should only be selected when the research field genuinely supports them. In practice, the safest compass is coherence: choose the design that the evidence maturity and clinical question can sustain.Table 1: Classification of review article types by purpose and reporting guidanceCRITICAL APPRAISAL: LOOKING BEYOND THE ABSTRACT A review cannot rely on what a study claims; it must examine what the study can support. Abstracts often present idealised summaries, selective endpoints or statistically significant findings without context.[8] Critical appraisal involves moving beyond the headline and into the details, specifically, the methodology, population, comparators, outcome definitions, attrition rates and risk of bias. A paper may be well-written yet clinically unusable if internal validity, external applicability or certainty of evidence is weak.[9] External applicability extends beyond population similarity to contextual feasibility. Much of the evidence base underpinning contemporary reviews originates from high-income healthcare systems with access to advanced infrastructure, technologies and perioperative resources. Translating such findings into low- and middle-income settings introduces conceptual challenges related to cost, workforce capability and system capacity. Reviews that fail to acknowledge these contextual constraints risk overstating clinical transferability. Responsible synthesis should therefore explicitly address not only what works, but where, for whom and under what practical conditions. Appraisal is not about fault-finding; it is about proportionate confidence. Tools such as Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) (for trials), Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) (observational data), A Measurement Tool to Assess Systematic Reviews-2 (AMSTAR 2) (systematic reviews) and Grading of Recommendations Assessment, Development and Evaluation (GRADE) (certainty of evidence) help anchor interpretation to defensible ground.[10] A study with high heterogeneity, unclear allocation concealment or inconsistent outcome reporting may still be publishable – but its conclusions must be treated with measured caution. In essence, critical appraisal prevents narrative enthusiasm from becoming clinical advice. BRIDGING THE GAP: TURNING LITERATURE INTO PRACTICE A review fulfils its purpose only when it helps the reader understand what the evidence means for real-world decisions. Summarising studies is not enough; the task is to translate findings into direction. This requires distinguishing between what the data show, what it suggests and what it cannot yet answer. Without that separation, reviews drift into speculation or unjustified clinical confidence. Effective evidence synthesis should therefore include not only results but also interpretive context, implications for practice and a clear demarcation of uncertainty.[11] Bridging literature to practice means acknowledging certainty and uncertainty with the same honesty. When evidence is consistent, conclusions may guide recommendations; when heterogeneous, they should highlight caution; and when insufficient, they should identify research gaps rather than fill them with assumptions. Guidance frameworks such as GRADE help translate evidence profiles into clinical judgments about recommendation strength.[12] A responsible review creates a map: where evidence is clear, where it is emerging and where silence is still meaningful. The goal is not to speak loudly, but to speak proportionately. Beyond summarising evidence, high-quality reviews carry an editorial responsibility to frame research gaps with strategic clarity. Merely stating that ‘further studies are needed’ offers little value unless uncertainty is translated into specific,

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.